Persistent and Circulating

Loise Ndung'u, Kelvin Thiong'o, Lewis Karani, Stephen Gitahi, Francis Kimani, Mathew Piero Ngugi, Daniel Kiboi

Abstract read

In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Loise Ndung'uDepartment of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi 00200, Kenya.ORCID 0000-0002-7800-3696

Kelvin Thiong'oCentre for Biotechnology Research and Development, Kenya Medical Research Institute, Nairobi 00200, Kenya.

Lewis KaraniCentre for Biotechnology Research and Development, Kenya Medical Research Institute, Nairobi 00200, Kenya.

Stephen GitahiDepartment of Natural Sciences, Catholic University of Eastern Africa, Nairobi 00200, Kenya.ORCID 0000-0003-4197-2968

Francis KimaniCentre for Biotechnology Research and Development, Kenya Medical Research Institute, Nairobi 00200, Kenya.ORCID 0000-0001-5150-2068

Mathew Piero NgugiDepartment for Biochemistry, Microbiology and Biotechnology, Kenyatta University, Nairobi 00100, Kenya.ORCID 0000-0002-0226-9092

Daniel KiboiDepartment of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi 00200, Kenya.ORCID 0000-0003-0797-7378

Funding

Gates Foundation INV-007175

6 · The paper itself

Abstract

Malaria in pregnancy remains a major driver of poor maternal and neonatal health outcomes in sub-Saharan Africa. For decades, intermittent preventive treatment in pregnancy (IPTp), with sulphadoxine-pyrimethamine (SP), has mitigated malaria-associated health risks, but concerns have been raised regarding accumulated

Indexed as

Dihydropteroate SynthaseMalaria, FalciparumMutationPlasmodium falciparumProtozoan ProteinsTetrahydrofolate DehydrogenaseAntimalarialsDrug CombinationsDrug ResistanceFemaleHaplotypesHumansKenyaPregnancyPyrimethamineSulfadoxineAntimalarialsDHFR protein, Plasmodium falciparumDihydropteroate SynthaseDrug Combinationsfanasil, pyrimethamine drug combinationProtozoan ProteinsPyrimethamineSulfadoxineTetrahydrofolate Dehydrogenaseantifolate resistanceBusia CountydhfrdhpsPlasmodium falciparumsulphadoxine-pyrimethamine

Identifiers

PMID41754485

DOI10.3390/pathogens15020233

PMCPMC12943605

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.